Subjective Cognitive Impairment Clinical Trials
2 recruiting trials for Subjective Cognitive Impairment. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Subjective Cognitive Impairment clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Manuel Montero Odasso (1), Dalarna University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Timed Up-and-Go (TUG single-task) (diagnostic_test, 1 trial), followed by Timed Up-and-Go dual-task (TUGdt), Clinical functional assessment.
Track Subjective Cognitive Impairment trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study
Motor slowing and cognitive slowing are more prevalent as we age. Importantly, the presence of both in an older person increases their risk of having dementia by ten times....
Uppsala-Dalarna Dementia and Gait Project
UDDGait™ is a multidisciplinary research project with the overreaching goal of providing an aid for early identification of cognitive impairment and risk of dementia development,...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Subjective Cognitive Impairment, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Subjective Cognitive Impairment, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Subjective Cognitive Impairment, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.